Resources

Filter by

January 24, 2025
Blog

Emerging Tools & Challenges in Pharmaceutical Government Pricing

Government Pricing

December 31, 2024
Blog

The Future of 340B and Independent Pharmacies in a Post-IRA World

Market Access Blogs

December 29, 2024
Blog

Pharma Inventory Roll Forward Monitoring & Management

Gross-to-Net

December 21, 2024
Blog

Navigating DSCSA Requirements with Compliance Solutions & Software

Contracts & Pricing

October 31, 2024
Blog

Industry Shifts: A Closer Look at Recent CMS and J&J Announcements

Contracts & Pricing

September 4, 2024
Blog

$35 Patient Out-of-Pocket Strategy: Impacts on Prescription Drug Affordability & Implications for Pharma Manufacturers

Contracts & Pricing

September 4, 2024
Blog

Key Developments in Pharmaceutical Pricing Regulations

Contracts & Pricing

August 29, 2024
Blog

Industry Updates, Biosimilar Barriers, and & the Impact of IRA Medicare Drug Price Negotiations

Market Access Blogs

July 30, 2024
Blog

The 340B Saga, New Orphan Drug Exclusion Criteria & Drug Shortages Challenges the US Healthcare System

Market Access Blogs

June 28, 2024
Blog

States Influence Drug Pricing and Access, Specialty Pharmacies Evolve to Accommodate Cell & Gene Therapies, and Walgreens Enters the CGT Arena

Market Access Blogs

June 13, 2024
Blog

The Wild Ride of Medicare Part D Payer Challenges on Expenditures and Concessions

Contracts & Pricing

May 30, 2024
Blog

IRA Part D Redesign, New Gene Therapies Give Hope for Patients, and Updates on the Regeneron Case

Market Access Blogs